| Kathleen Hamilton Tarkington, | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 233-3994 | |
| Not Available |
| Full Name | Kathleen Hamilton Tarkington |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487147997 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 055.0031393 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
An immune-based therapy developed at Roswell Park Cancer Institute is moving forward with its third clinical trial. The early-stage clinical trial will assess whether SurVaxM — a cancer vaccine developed at Roswell Park — is a safe and effective treatment option for patients with multiple myeloma, a rare type of blood cancer.
RainDance Technologies, Inc., the Digital Biology Company, and Ambry Genetics, today announced the launch of a comprehensive targeted sequencing panel to screen genes involved with drug absorption, distribution, metabolism, and excretion (ADME) research. The ADMESeq Research Screening Panel enables researchers to simultaneously interrogate 242 known pharmacogenetic genes using next-generation sequencing (NGS) systems.
The current issue of the Lancet features a seminar on tuberculosis that "presents current perspectives on the scale of the epidemic, the pathogen and the host response, present and emerging methods for disease control, and the ongoing challenge of tuberculosis control in adults in the 21st century".
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system therapeutics, today announced clinical results with its investigational new drug, Serdaxin®for the treatment of major depressive disorder.
As medical personnel and public health officials are responding to the first reported cases of Ebola Virus in the United States, many of the safety and treatment procedures for treating the virus and preventing its spread are being reexamined. One of the tenets for minimizing the risk of spreading the disease has been a 21-day quarantine period for individuals who might have been exposed to the virus. But a new study by Charles Haas, PhD, a professor in Drexel's College of Engineering, suggests that 21 days might not be enough to completely prevent spread of the virus.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Hamilton Tarkington, 102 Seymour St Apt 109, Williston, VT 05495-4505 Ph: (802) 233-3994 | Kathleen Hamilton Tarkington, 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 233-3994 |
News Archive
An immune-based therapy developed at Roswell Park Cancer Institute is moving forward with its third clinical trial. The early-stage clinical trial will assess whether SurVaxM — a cancer vaccine developed at Roswell Park — is a safe and effective treatment option for patients with multiple myeloma, a rare type of blood cancer.
RainDance Technologies, Inc., the Digital Biology Company, and Ambry Genetics, today announced the launch of a comprehensive targeted sequencing panel to screen genes involved with drug absorption, distribution, metabolism, and excretion (ADME) research. The ADMESeq Research Screening Panel enables researchers to simultaneously interrogate 242 known pharmacogenetic genes using next-generation sequencing (NGS) systems.
The current issue of the Lancet features a seminar on tuberculosis that "presents current perspectives on the scale of the epidemic, the pathogen and the host response, present and emerging methods for disease control, and the ongoing challenge of tuberculosis control in adults in the 21st century".
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system therapeutics, today announced clinical results with its investigational new drug, Serdaxin®for the treatment of major depressive disorder.
As medical personnel and public health officials are responding to the first reported cases of Ebola Virus in the United States, many of the safety and treatment procedures for treating the virus and preventing its spread are being reexamined. One of the tenets for minimizing the risk of spreading the disease has been a 21-day quarantine period for individuals who might have been exposed to the virus. But a new study by Charles Haas, PhD, a professor in Drexel's College of Engineering, suggests that 21 days might not be enough to completely prevent spread of the virus.
› Verified 7 days ago
Dr. Kristen M. Daniels, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave., Uvm Medical Center - Surgery/plastics, Burlington, VT 05401 Phone: 802-847-3340 Fax: 802-847-7083 | |
Kimberly Ann Holbrook, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, 354mp2, Burlington, VT 05401 Phone: 802-847-3496 Fax: 802-847-0574 | |
Mrs. Cheryl Gagnon, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-864-0111 | |
Kirsten Lanpher, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4590 Fax: 802-847-0654 | |
Ms. Christine Yvette O'neill, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fahc Radiology Department, Burlington, VT 05401 Phone: 802-847-8359 | |
Oliver Barkley, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, 205wp1, Burlington, VT 05401 Phone: 802-847-3982 | |
Nicole Kimball, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 173 Saint Paul St, Burlington, VT 05401 Phone: 866-476-1321 |